[1]中国国家药监局药品审评中心(CDE)官网. Retrieved June 20 , 2023. From https://www.cde.org.cn/main/xxgk/listpage/4b5255eb0a84820cef4ca3e8b6bbe20c
[2]开创行业先河!勃林格殷格翰新药圣利卓全球率先在华递交新适应症上市申请. Retrieved May 11, 2023. From https://mp.weixin.qq.com/s/jIyeG0xELbwaw1KCwc_rPQ
[3] Spesolimab meets primary and key secondary endpoint for prevention of generalized pustular psoriasis flares. Retrieved February 2, 2023, from https://www.businesswire.com/news/home/20230129005023/en
本文来自药明康德内容团队,欢迎个人转发至朋友圈,谢绝媒体或机构未经授权以任何形式转载至其他平台。转载授权请在「医药观澜」微信公众号留言联系我们。其他合作需求,请联系wuxi_media@wuxiapptec.com。